Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 1, 2010

Premium

PrimeraDx said this week that it has appointed Matthew McManus as president and CEO.

McManus, who will also join PrimeraDx's board of directors, was previously head of Cleveland Clinic Laboratories and COO of the Pathology and Laboratory Medicine Institute. Prior to this, he was a medical scientist for the Novartis Institutes for Biomedical Research Drug Discovery Incubator. He has also worked at McKinsey & Company and Proctor & Gamble. He holds an MD and PhD from the University of Pennsylvania School of Medicine and an MBA from Boston College.


HTG said this week that it has appointed John Wineman as vice president of new business development, western region; and Thomas Vasicek as vice president of clinical programs and product innovation.

Wineman will be responsible for commercial sales and new business growth for the western region of North America and Asia, HTG said. Prior to joining HTG, Wineman was director of business development for FEI's Life Science division. Prior to that, he serves as director of strategic marketing and director of corporate development for Roche Diagnostics' Ventana Medical Systems group.

Wineman has also worked for LifeSpan Biosciences, Becton-Dickinson, and Bio-Rad Laboratories. He holds an MBA from San Diego State University and a BS in biology from Oregon State University.

Vasicek will be responsible for leading HTG's clinical programs and establishing HTG's new assay innovation roadmap, HTG said. Prior to joining the company, Vasicek was senior director of medical innovation for Roche's Ventana Medical Systems group. Prior to that, he served as senior director of bioscience technology development at Medtronic.

Vasicek has also served as vice president of business development for Solexa/Lynx Therapeutics; CSO for LabSeek Scientific Collaboration; director of commercial technology for Corning's life sciences group; senior scientist at Millennium Pharmaceuticals; and a visiting scientist at the Whitehead Institute. He holds a PhD in genetics from Harvard University and completed his postdoc at Princeton University.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more